Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EW Group is a large, privately held German holding company specializing in animal and plant genetics, animal health, nutrition, diagnostics, and agricultural technology, serving the global food and agriculture value chain. The group is a dominant player in poultry, layer, turkey, and fish genetics, with subsidiaries such as Aviagen and Hy-Line International. It has expanded into animal health, diagnostics (including food safety), and nutrition via targeted acquisitions. The company emphasizes research-driven innovation, sustainability, and operational independence for its subsidiaries. There is no evidence of a pipeline of experimental drugs targeting human diseases; its focus is on animal and plant biotechnology, veterinary medicine, and agri-food solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EW Group.